Berger, Annemarie
Groh, Ana M.
Diaz, Damian
Canchola, Jesse A.
Toptan, Tuna
Ciesek, Sandra
Jarem, Daniel
Kuchta, Alison L.
Moonsamy, Priscilla
Vehreschild, Maria J. G. T.
Funding for this research was provided by:
Roche Molecular Systems, Pleasanton, CA, USA
Article History
Received: 8 May 2025
Accepted: 9 September 2025
First Online: 23 September 2025
Declarations
:
: Annemarie Berger has received speaker fees and travel costs from Roche Diagnostics. Ana M. Groh, Damian Diaz, Tuna Toptan, and Sandra Ciesek have no conflicts of interest to disclose. Jesse A. Canchola, Daniel Jarem, and Alison Kuchta are employees of Roche Molecular Systems and hold F Hoffman-La Roche shares. Priscilla Moonsamy is an employee of Roche Molecular Systems. Maria J.G.T. Vehreschild has received grants from Heel, MSD, Roche and Tillotts; consulting fees from Bactolife, Bioaster, Ecraid, Eumedica, Gilead, GSK, Pfizer and Tillotts; and honoraria from Akademie für Infektionsmedizin, AstraZeneca, bioMerieux, Biotest, DGI, European Society of Neurogastroenterology, Falk Foundation, FomF GmbH, Gilead, GSK, Helios Kliniken, Hessisches Landessozialgericht, Infektio Forum, Janssen Cilag GmbH, Klinikum Kasseln, Landesärztekammer Hessen, LMU Kliniken, MSD, Pfizer, Streamed up, St. Vincent Hospital and Tillotts.
: Ethical approvals were obtained from Ethikkommission des Fachbereichs Medizin der Goethe-Universität c/o Universitätsklinikum (Reference number 2021-119-MPG). The study was performed in accordance with the Helsinki Declaration of 1964, and each participant provided informed consent.